Etiology and Outcomes of Acute Infectious Conjunctivitis in Children.

Antibiotic Stewardship Pediatrics Pink Eye

Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
18 Oct 2024
Historique:
received: 28 06 2024
revised: 10 09 2024
accepted: 15 10 2024
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 20 10 2024
Statut: aheadofprint

Résumé

To determine the causes of conjunctivitis and whether clinical presentations and outcomes differ by pathogen. This multicenter, case-control study enrolled 390 children (194 cases, 196 controls) whose conjunctival samples were tested for bacterial and viral pathogens. Caregivers completed surveys tracking symptoms, antibiotic use, school attendance, and adverse events. The outcomes analyzed included the prevalence of microorganisms detected by PCR in cases versus controls, symptoms, rate of resolution by day 5, school/childcare attendance, and parent-reported antibiotic-related adverse incidents. Most cases (148, 76%) and controls (112, 57%) had bacteria identified, although only detection of Haemophilus influenzae was associated with conjunctivitis (aOR 4.59, 95% CI 2.86, 7.37). Purulent discharge was associated with H. influenzae (aOR 2.47, 95% CI 1.23, 5.01) and occurred in 92 (77%) cases in which H. influenzae was detected and 39 (53%) in which H. influenzae was not detected. Improvement (186, 96%) and resolution (166, 86%) were observed by day 5 for most children and did not differ based on ophthalmic antibiotic use. Caregivers reported antibiotic-associated adverse events for 21 (20%) children with 8 (8%) requiring a medical visit. Only H. influenzae was significantly associated with conjunctivitis. Symptoms did not differ in children with or without bacteria detected by PCR. Independent of antibiotic use, most children experienced resolution by day 5, but parents reported adverse events in 20% of children treated with topical antibiotics, underscoring the importance of judicious prescribing.

Identifiants

pubmed: 39428088
pii: S0022-3476(24)00471-2
doi: 10.1016/j.jpeds.2024.114368
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114368

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Auteurs

Holly M Frost (HM)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA; Department of Pediatrics, Denver Health and Hospital Authority, Denver, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO USA. Electronic address: holly.frost@imail.org.

Timothy C Jenkins (TC)

Division of Infectious Diseases, Department of Medicine, Denver Health and Hospital Authority, Denver, CO, USA; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, CO USA.

Jennifer C Meece (JC)

Marshfield Clinic Research Institute, Marshfield, WI, USA.

Connie Savor-Price (C)

Division of Infectious Diseases, Department of Medicine, Denver Health and Hospital Authority, Denver, CO, USA; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, CO USA.

Michael L Wilson (ML)

Department of Pathology, Denver Health and Hospital Authority, Denver, CO, USA; Department of Pathology, University of Colorado School of Medicine, Aurora, CO USA.

Amy Keith (A)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Amy Stein (A)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Theresa Morin (T)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Shaun Cosgrove (S)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Melanie Kiernan (M)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Thresia Sebastian (T)

Center for Health Systems Research, Denver Health and Hospital Authority, Denver, CO, USA.

Samuel R Dominguez (SR)

Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

Classifications MeSH